180 related articles for article (PubMed ID: 19098283)
1. Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a).
Wang YT; von Zychlinski A; McCormick SP
J Lipid Res; 2009 May; 50(5):846-53. PubMed ID: 19098283
[TBL] [Abstract][Full Text] [Related]
2. Mutation of lysine residues in apolipoprotein B-100 causes defective lipoprotein[a] formation.
Liu CY; Broadhurst R; Marcovina SM; McCormick SP
J Lipid Res; 2004 Jan; 45(1):63-70. PubMed ID: 13130121
[TBL] [Abstract][Full Text] [Related]
3. Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a).
Becker L; McLeod RS; Marcovina SM; Yao Z; Koschinsky ML
J Biol Chem; 2001 Sep; 276(39):36155-62. PubMed ID: 11473115
[TBL] [Abstract][Full Text] [Related]
4. Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein.
McCormick SP; Linton MF; Hobbs HH; Taylor S; Curtiss LK; Young SG
J Biol Chem; 1994 Sep; 269(39):24284-9. PubMed ID: 7929084
[TBL] [Abstract][Full Text] [Related]
5. High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.
Schneider M; Witztum JL; Young SG; Ludwig EH; Miller ER; Tsimikas S; Curtiss LK; Marcovina SM; Taylor JM; Lawn RM; Innerarity TL; Pitas RE
J Lipid Res; 2005 Apr; 46(4):769-78. PubMed ID: 15654123
[TBL] [Abstract][Full Text] [Related]
6. A quantitative assay for the non-covalent association between apolipoprotein[a] and apolipoprotein B: an alternative measure of Lp[a] assembly.
Dardik BN; Schwartzkopf CD; Stevens DE; Chatelain RE
J Lipid Res; 2000 Jun; 41(6):1013-9. PubMed ID: 10828094
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the interaction between mouse apolipoprotein B100 and apolipoprotein(a).
Cheesman EJ; Sharp RJ; Zlot CH; Liu CY; Taylor S; Marcovina SM; Young SG; McCormick SP
J Biol Chem; 2000 Sep; 275(36):28195-200. PubMed ID: 10837476
[TBL] [Abstract][Full Text] [Related]
8. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
9. Interaction of LDL, Lp[a], and reduced Lp[a] with monoclonal antibodies against apoB.
Gries A; Fievet C; Marcovina S; Nimpf J; Wurm H; Mezdour H; Fruchart JC; Kostner GM
J Lipid Res; 1988 Jan; 29(1):1-8. PubMed ID: 2451704
[TBL] [Abstract][Full Text] [Related]
10. Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a).
Ye SQ; Trieu VN; Stiers DL; McConathy WJ
J Biol Chem; 1988 May; 263(13):6337-43. PubMed ID: 2966154
[TBL] [Abstract][Full Text] [Related]
11. Structural features of apolipoprotein B synthetic peptides that inhibit lipoprotein(a) assembly.
Sharp RJ; Perugini MA; Marcovina SM; McCormick SP
J Lipid Res; 2004 Dec; 45(12):2227-34. PubMed ID: 15375179
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S
Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084
[TBL] [Abstract][Full Text] [Related]
13. Primary structure of apoB-100.
Yang C; Gu ZW; Yang M; Gotto AM
Chem Phys Lipids; 1994 Jan; 67-68():99-104. PubMed ID: 8187250
[TBL] [Abstract][Full Text] [Related]
14. A synthetic peptide that inhibits lipoprotein(a) assembly.
Sharp RJ; Perugini MA; Marcovina SM; McCormick SP
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):502-7. PubMed ID: 12615683
[TBL] [Abstract][Full Text] [Related]
15. The binding of animal low-density lipoproteins to human apolipoprotein(a).
Trieu VN; McConathy WJ
Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):899-904. PubMed ID: 7639708
[TBL] [Abstract][Full Text] [Related]
16. Site-specific mutagenesis demonstrates that cysteine 4326 of apolipoprotein B is required for covalent linkage with apolipoprotein (a) in vivo.
Callow MJ; Rubin EM
J Biol Chem; 1995 Oct; 270(41):23914-7. PubMed ID: 7592581
[TBL] [Abstract][Full Text] [Related]
17. Quantification of apo[a] and apoB in human atherosclerotic lesions.
Pepin JM; O'Neil JA; Hoff HF
J Lipid Res; 1991 Feb; 32(2):317-27. PubMed ID: 1829751
[TBL] [Abstract][Full Text] [Related]
18. Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
Callow MJ; Stoltzfus LJ; Lawn RM; Rubin EM
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2130-4. PubMed ID: 8134359
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
[TBL] [Abstract][Full Text] [Related]
20. In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a).
Frischmann ME; Ikewaki K; Trenkwalder E; Lamina C; Dieplinger B; Soufi M; Schweer H; Schaefer JR; König P; Kronenberg F; Dieplinger H
Atherosclerosis; 2012 Dec; 225(2):322-7. PubMed ID: 23099120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
